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Accumulation of visceral fat leads to metabolic syndrome and increases risks of cere-
bro-cardiovascular diseases, which should be recognized and improved at the early 
stage in general population. Accurate measurement of visceral fat area (VFA) is commonly 
performed by the abdominal cross-sectional image measured by computed tomography 
scan, which is, however, limited due to the radiation exposure. The bioelectrical imped-
ance analysis (OMRON, HDS-2000 DUALSCANR) has been recently developed to mea-
sure VFA, which is more easily accessible modality. In the present study, we investigated 
the clinical usefulness of DUALSCANR in 226 subjects who received health examination, 
including blood chemistries, electrocardiography, cardio, and carotid ultrasonography. 
VFA was measured within only just 5 min. Average of VFA was 83.5 ± 36.3 cm2 in men, 
and 64.8 ± 28.0 cm2 in women, which was correlated to weight (r = 0.7404, p < 0.0001), 
body mass index (BMI) (r = 0.7320, p < 0.0001), and waist circumstance (r = 0.7393, 
p  <  0.0001). In multivariate analyses, VFA was significantly associated with weight 
(p < 0.0001), BMI (p < 0.0001), and waist circumstance (p < 0.0001). Compared to the 
group of smaller waist and normal BMI, VFA was significantly increased (p < 0.0001) 
in the group of larger waist and obese subjects. In conclusion, these results indicated 
that DUALSCANR is useful to measure VFA easily in general population, even in a large 
number of subjects.
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inTrODUcTiOn
Obesity has been rapidly increasing over the last decades all over the world (1), which is a 
serious concern and should be recognized and improved at the early stage in general population, 
especially in the aspects of the increased risk of cardiovascular diseases as primary prevention 
(2). It is simple for obesity assessment to measure body mass index (BMI), waist circumference, 
or waist-to-hip ratio. However, it is clinically important to distinguish visceral from subcutane-
ous adipose tissues by using imaging techniques, such as magnetic resonance imaging (MRI) or 
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computed tomography (CT) scan (3, 4), because visceral fat 
accumulation was found to be specifically associated with the 
metabolic alterations of obesity, both in men and women (5). 
Serial-slice CT is able to evaluate the visceral adipose tissue 
(VAT) in detail (6). Dual-energy X-ray absorptiometry (DEXA) 
is usually used to measure total body fat, which has been also 
used to measure central abdominal fat (7). It has been reported 
that visceral fat measured by CT scan has a strong correlation 
with central abdominal fat measured by DEXA (7–14).
However, these methods are limited in the clinical use, due 
to the radiation exposure and the cost of techniques, which is 
not suitable to general health checkup examination. Where more 
easily accessible modality at lower cost should be developed, 
the bioelectrical impedance analysis (BIA) has been recently 
developed, which is used in population and clinical studies as 
a technique to estimate body composition (15–19). Unno and 
colleagues (15) found that VFA estimated by BIA is useful for 
detection of metabolic syndrome (MetS), as consistently reported 
by other studies (16–20).
Therefore, in the present study, we aimed to examine whether 




A total of 226 subjects (87 males and 139 females: aged 
40–90 years) received a population-based health examination in 
Uku town, a fishing community in southwestern Japan in 2011. 
This town is an isolated island in Sasebo city, located in Nagasaki 
prefecture, and the total population is about 3,700. A detailed 
content of the recent survey in the same district was previously 
described (21, 22).
Data collection
Height and weight were measured, and BMI was calculated as 
weight (kilograms) divided by the square of height (square 
meters) as an index of the presence or absence of obesity. Waist 
circumference was measured at the level of the umbilicus in a 
standing position. Blood pressure (BP) was measured twice with 
the subjects in the sitting (first) and supine (second) position. 
Vigorous physical activity and smoking were avoided for at least 
30 min before BP measurements. The second BP with the fifth 
phase diastolic pressure was used for analysis.
Blood was drawn from the antecubital vein for determina-
tions of lipids profiles [total cholesterol, high-density lipopro-
tein cholesterol (HDL-c), low-density lipoprotein cholesterol 
(LDL-c), and triglycerides], creatinine, uric acid (UA), fasting 
plasma glucose (FPG), glycated hemoglobin A1c [HbA1c(NGSP)], 
and high-sensitivity C-reactive protein (hs-CRP) in the morn-
ing after a 12-h fast. Fasting blood samples were centrifuged 
within 1 h after the collection. Estimated glomerular filtration 
rate (eGFR) was calculated using the modification of diet in 
renal disease (MDRD) study equation modified with a Japanese 
 coefficient (23).
All subjects underwent the new abdominal BIA method 
(OMRON, HDS-2000 DUALSCANR) to estimate VFA in the 
morning after a 12-h fast. The voltage occurring at the flank to 
the flow of current between the umbilicus and the back correlates 
significantly with VFA and is unaffected by subcutaneous fat 
area. The voltage becomes larger as VFA even in the subjects 
with the same waist circumference because the electric resist-
ance of intra-abdominal fat is greater than that of fat-free mass, 
and the density of the equipotential lines between two electrodes 
becomes denser. Using this method, we measured VFA of indi-
viduals within 5 min.
C-IMT of the common carotid artery was determined by 
using duplex ultrasonography (Sonosite “TITAN,” ALOKA) 
with a 10-MHz transducer in the supine position. Longitudinal 
B-mode images at the diastolic phase of the cardiac cycle were 
recorded by a single trained technician who was blinded to the 
subjects’ background. We measured the only far site of the wall 
of c-IMT. The images were magnified and measured on the 
screen and printed with a high-resolution line recorder (LSR-
100A, Toshiba). We measured c-IMT according to the originally 
described method published in Circulation (24). Briefly, the 
c-IMT defined by Pignoli et al. (24) was measured as the distance 
from the leading edge of the first echogenic line to the leading 
edge of the second echogenic line. The first line represented the 
lumen–intimal interface; the collagen-containing upper layer 
of the tunica adventitia formed the second line. At each longi-
tudinal projection, the site of the greatest thickness, including 
plaque, was sought along the arterial walls nearest and farthest 
from the skin from the common carotid artery to the internal 
carotid artery. Three determinations of c-IMT of one artery 
were conducted at the site of the greatest thickness and at two 
other points, 1  cm upstream and 1  cm downstream from this 
site. The averaged value among the six IMTs (three from the left 
and three from the right) was used as the representative value 
for each individual.
This study was approved by the mayor, by the welfare depart-
ment of Uku town, and by the Research Ethics Committee of the 
Kurume University School of Medicine (Process numbers 2284), 
approved the study in conformity with the principles embodied 
in the declaration of Helsinki. All participants were informed 
about research procedures and risks before signing an informed 
consent.
statistical analysis
Results were presented as means ±  SDs. Because of skewed 
distributions, natural logarithmic (ln) transformations were 
performed for triglycerides and hs-CRP. Log-transformed val-
ues were reconverted to antilogarithm forms in the tables. The 
medications for hypertension, dyslipidemia, and diabetes mel-
litus were coded as dummy variables. Gender, smoking habits, 
and alcohol intake were also coded as dummy variables. First, 
we performed univariate analysis for VFA levels as depend-
ent variable. Second, multivariate analysis after adjustments 
for age and sex was performed for correlates of VFA levels. 
Finally, comparisons of various parameters between VFA levels 
(VFA < 100 cm2 vs. VFA ≥ 100 cm2) was performed. Statistical 
significance was defined as p < 0.05. All statistical analyses were 
performed using the SAS system (Release 9.3, SAS Institute, 
Cary, NC, USA).
TaBle 1 | characteristics of study subjects.
Parameters Males Females Total
Number 87 139 226
Age (years) 68.3 ± 8.2 66.4 ± 10.6 67.1 ± 9.8
Weight (kg) 64.5 ± 10.5 54.2 ± 9.0 58.2 ± 10.8
BMI (kg/m2) 24.0 ± 3.0 23.7 ± 3.5 23.8 ± 3.3
Waist (cm) 86.6 ± 8.5 83.9 ± 9.9 85.0 ± 9.5
Systolic BP (mmHg) 135.4 ± 17.4 139.1 ± 20.4 137.7 ± 19.4
Diastolic BP (mmHg) 86.8 ± 8.9 84.3 ± 9.9 85.3 ± 9.6
Total cholesterol (mg/dl) 194.7 ± 43.8 207.6 ± 33.9 202.7 ± 38.4
HDL-cholesterol (mg/dl) 55.1 ± 14.3 65.4 ± 14.7 63.7 ± 36.4
LDL-cholesterol (mg/dl) 115.1 ± 34.3 121.1 ± 29.7 118.8 ± 31.6
Triglycerides (mg/dl)a (min–max) 93.0 (34–399) 75.9 (37–250) 82.2 (34–399)
FPG (mg/dl) 110.7 ± 27.4 93.6 ± 10.0 100.1 ± 20.4
HbA1c (NGSP) (%) 5.7 ± 0.8 5.5 ± 0.5 5.5 ± 0.7
eGFR (ml/min/1.73 m2) 75.1 ± 17.7 72.8 ± 16.6 73.7 ± 17.1
Uric acid (mg/dl) 6.0 ± 1.2 4.7 ± 1.1 5.2 ± 1.3
hs-CRP (mg/dl)a (min–max) 0.050 (0.004–3.830) 0.037 (0.004–4.940) 0.042 (0.004–4.940)
C-IMT (mm) 0.8 ± 0.2 0.7 ± 0.1 0.8 ± 0.2
Hypertensive medication (%) 52.9 39.6 44.7
Diabetic medication (%) 14.9 5.0 8.9
Dyslipidemic medication (%) 21.8 28.8 26.1
Habitual smoking (%) 23.0 2.2 10.2
Alcohol intake (%) 54.0 6.5 24.8
VFA (cm2) 83.5 ± 36.3 64.8 ± 28.0 72.3 ± 32.8
Data are means ± SDs, geometric mean, range, or percent.
VFA, visceral fat area; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; FPG, fasting plasma glucose; eGFR, estimated 
glomerular filtration rate; hs-CRP, high sensitivity C-reactive protein; C-IMT, carotid intima-media thickness.
aLog-transformed values were used for the analysis.
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resUlTs
Demographic and clinical characteristics of the enrolled study 
subjects are presented in Table  1. Mean values of VFA were 
83.5 cm2 in men and 64.8 cm2 in women, respectively, indicating 
that most of the subjects were non-obese. Mean VFA values of 
most subjects were within normal range. The prevalence of VFA 
in total and both genders was shown in Figure 1. VFA levels had 
a normal distribution in both genders. The association between 
VFA values and waist, weight, and BMI were demonstrated in 
Figure 2. Strong association between VFA and waist (r = 0.739, 
p < 0.0001), VFA and weight (r = 0.740, p < 0.0001), and VFA 
and BMI (r = 0.732, p < 0.0001) were observed.
Univariate analysis for VFA levels as dependent variable 
stratified by gender was shown in Table 2. Weight (p < 0.0001), 
BMI (p < 0.0001), waist (p < 0.0001), triglycerides (p < 0.0001), 
FPG (p <  0.01), hypertensive medication (p <  0.05), dyslipi-
demic medication (p < 0.05), and alcohol intake (p < 0.01) were 
significantly associated with VFA areas in males. Age (p < 0.01), 
weight (p <  0.0001), BMI (p <  0.0001), waist (p <  0.0001), 
systolic BP (p  <  0.05), HDL-c (p  <  0.0001; inversely), tri-
glycerides (p <  0.01), FPG (p <  0.01), HbA1c (p <  0.01), UA 
(p < 0.0001), hs-CRP (p < 0.05), c-IMT (p < 0.01), hypertensive 
medication (p  <  0.05), diabetic medication (p  <  0.01), and 
dyslipidemic medication (p < 0.001) were significantly associ-
ated with VFA areas in females. Table 3 shows the multivariate 
analysis adjusted for age for VFA levels as dependent variable. 
Weight (p <  0.0001), BMI (p <  0.0001), waist (p <  0.0001), 
triglycerides (p  <  0.0001), FPG (p  <  0.05), hypertensive 
medication (p < 0.05), dyslipidemic medication (p < 0.05), and 
alcohol intake (p < 0.01) in males. Weight (p < 0.0001), BMI 
(p < 0.0001), waist (p < 0.0001), HDL-c (p < 0.001; inversely), 
triglycerides (p < 0.01), FPG (p < 0.01), HbA1c (p < 0.01), UA 
(p < 0.0001), hs-CRP (p < 0.05), diabetic medication (p < 0.05), 
and dyslipidemic medication (p  <  0.01) were significantly 
associated with VFA areas in females. In multivariate analysis 
for VFA levels after adjustment for age, sex, and medications 
for hypertension, diabetes, and dyslipidemia, the significance of 
weight (p < 0.0001), BMI (p < 0.0001), and waist (p < 0.0001) 
in both genders were still remained. In order to investigate the 
impacts of waist and BMI on VFA, we create the hierarchical 
model stratified two groups of waist and BMI adjustment for 
age and sex (Figure 3). Compared to the group of smaller waist 
and normal BMI, VFA was significantly increased (p < 0.0001) 
in the group of larger waist and obese subjects.
Comparison between various parameters stratified by 
VFA (<100 vs. ≧100  cm2) was demonstrated in Table  4. Male 
gender (p  <  0.05), weight (p  <  0.0001), BMI (p  <  0.0001), 
waist (p <  0.0001), HDL-c (p <  0.05; inversely), triglycerides 
(p < 0.0001), FPG (p < 0.0001), HbA1c (p < 0.01), UA (p < 0.01), 
hs-CRP (p  <  0.05), and c-IMT (p  <  0.05) were significantly 
associated with elevated VFA areas (≧100 cm2).
To compare the usefulness between VFA and BMI, we per-
formed the multiple stepwise regression analysis. Then, we found 
that triglycerides (p <  0.0001), FPG (p =  0.0002), and HDL-c 
(p  =  0.0144; inversely) were independently related to VFA 
(R2 = 0.2698), whereas; FPG (p = 0.0001), HDL-c (p < 0.0049; 
inversely), and age (p =  0.0262) were independently related to 
FigUre 2 | The correlation between VFa values and waist, weight, and body mass index were demonstrated.
FigUre 1 | The prevalence of VFa in total and both sexes were shown.
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BMI (R2 =  0.1375), suggesting that VFA is stronger statistical 
power to find out not only obese subjects but also subjects with 
accumulation of visceral fat than BMI.
DiscUssiOn
The adipocytokines secreted by excessive VFA are closely linked 
with metabolic disorders, such as type 2 diabetes, hypertension, 
and dyslipidemia, which develop various metabolic and cardio-
vascular disorders during several decades (25). Therefore, it is 
important for each individual in general population to recognize 
VFA for the primary prevention of cerebro-cardiovascular dis-
eases in health checkup examinations, which should be simple 
and at low cost. In the present study, we have indicated that 
the VFA measurement by a new BIA method is useful and 
suitable to general population in the evaluation of adiposity of 




Weight 2.8835 0.2405 <0.0001
BMI 10.2088 0.7730 <0.0001
Waist 3.5655 0.2586 <0.0001
Systolic BP 0.3025 0.2279 0.1881
Diastolic BP 0.6924 0.4517 0.1292
Total cholesterol 0.1282 0.0969 0.1896
HDL-cholesterol −0.1960 0.2824 0.0828
LDL-cholesterol 0.1638 0.1215 0.1813
Triglyceridesa 34.6199 6.8524 <0.0001
FPG 0.3722 0.1420 0.0105
HbA1c 9.4693 4.9282 0.0582
Uric acid (UA) 0.1576 3.3289 0.9623
hs-CRPa 4.3902 3.2070 0.1748
C-IMT 38.2550 24.1002 0.1209
Hypertensive medication 21.1059 8.3337 0.0132
Diabetic medication −0.8550 11.0571 0.9385
Dyslipidemic medication 19.8615 9.4746 0.0391
Habitual smoking −18.1511 9.4618 0.0585
Alcohol intake 20.3310 7.6233 0.0092
Females
Weight 2.4767 0.1821 <0.0001
BMI 6.2924 0.4589 <0.0001
Waist 2.0154 0.1943 <0.0001
Systolic BP 0.1855 0.1249 0.1399
Diastolic BP −0.1495 0.2361 0.5709
Total cholesterol 0.0162 0.0727 0.8238
HDL-cholesterol −0.5591 0.1635 0.0008
LDL-cholesterol 0.1528 0.0825 0.0662
Triglyceridesa 15.9006 5.8434 0.0074
FPG 0.7485 0.2302 0.0015
HbA1c 13.5430 4.4821 0.0030
UA 10.2107 2.0699 <0.0001
hs-CRPa 4.2949 1.7938 0.0181
C-IMT 32.7282 23.0059 0.1573
Hypertensive medication 4.8418 5.5088 0.3811
Diabetic medication 26.5890 10.4157 0.0119
Dyslipidemic medication 16.9170 5.0792 0.0011
Habitual smoking −14.2617 16.0081 0.3747
Alcohol intake −5.4078 9.4861 0.5696
VFA, visceral fat area; BMI, body mass index; BP, blood pressure; HDL, high-density 
lipoprotein; LDL, low-density lipoprotein; FPG, fasting plasma glucose; hs-CRP, high 
sensitivity C-reactive protein; C-IMT, carotid intima-media thickness.
aLog-transformed values were used for the analysis.
TaBle 2 | Univariate analysis for VFa levels as dependent variable.
β se p-Value
Males
Age −0.1568 0.4807 0.7451
Weight 2.7065 0.2402 <0.0001
BMI 10.1890 0.7671 <0.0001
Waist 3.5623 0.2567 <0.0001
Systolic BP 0.2806 0.2235 0.2128
Diastolic BP 0.6907 0.4380 0.1186
Total cholesterol 0.1245 0.0906 0.1733
HDL-cholesterol −0.4610 0.2767 0.0995
LDL-cholesterol 0.1626 0.1159 0.1644
Triglyceridesa 34.0759 6.7193 <0.0001
FPG 0.3740 0.1409 0.0095
HbA1c 0.5024 4.8318 0.0526
Uric acid (UA) 0.2174 3.3067 0.9477
hs-CRPa 4.2617 3.1802 0.1839
C-IMT 35.1616 23.8340 0.1439
Hypertensive medication 16.6439 7.6617 0.0326
Diabetic medication −0.6386 10.9786 0.9538
Dyslipidemic medication 19.9281 9.4195 0.0373
Habitual smoking −16.2424 9.1387 0.0791
Alcohol intake 20.3688 7.5806 0.0087
Females
Age 0.6573 0.2308 0.0051
Weight 2.1149 0.2131 <0.0001
BMI 6.2002 0.4999 <0.0001
Waist 2.0749 0.1893 <0.0001
Systolic BP 0.2591 0.1233 0.0376
Diastolic BP −0.1734 0.2701 0.5219
Total cholesterol −0.0260 0.0730 0.7226
HDL-cholesterol −0.6418 0.1596 <0.0001
LDL-cholesterol 0.1157 0.0843 0.1722
Triglyceridesa 17.2461 5.9565 0.0045
FPG 0.7795 0.2358 0.0012
HbA1c 13.2390 4.6175 0.0049
UA 10.7302 2.1050 <0.0001
hs-CRPa 4.5772 1.8357 0.0139
C-IMT 53.0877 19.5612 0.0076
Hypertensive medication 10.1500 4.9929 0.0441
Diabetic medication 28.8420 10.6327 0.0076
Dyslipidemic medication 19.0611 5.0749 0.0003
Habitual smoking −17.9344 16.3603 0.2750
Alcohol intake −7.6024 9.6991 0.4346
VFA, visceral fat area; BMI, body mass index; BP, blood pressure; HDL, high-density 
lipoprotein; LDL, low-density lipoprotein; FPG, fasting plasma glucose; hs-CRP, high 
sensitivity C-reactive protein; C-IMT, carotid intima-media thickness.
aLog-transformed values were used for the analysis.
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individuals. Conventional BIA approaches have estimated total 
fat content but not regional fat distribution (26, 27). Compared 
to the new method, waist circumference underestimates visceral 
fat amount because of the accumulation of abdominal subcu-
taneous fat (28–30). From the results of hierarchical multiple 
regression, our data may propose that the usefulness of VFA by 
DUALSCAN shows its superiority over waist and BMI in this 
study setting. In the multiple stepwise regression analysis, VFA 
is stronger statistical power to find out not only obese subjects 
but also subjects with accumulation of visceral fat than BMI. 
The abdominal dual BIA method of the DUALACAN seemed to 
measure VFA more precisely with less influence of subcutane-
ous fat area compared with the conventional whole-body BIA 
method (31). Because VSA measurement using the DUALSCAN 
showed a closer correlation with metabolic variables than 
whole-body BIA method in a health checkup examination, the 
device was approved as medical device by Health, Labour, and 
Welfare Ministry since 2011 in Japan (32). Moreover, the evalu-
ation of VFA by the BIA is really a simple and easily accessible 
device even in a health checkup examination in Japanese general 
population.
Comparisons between DEXA or abdominal CT and BIA have 
been already performed in healthy adults (33, 34) and overweight 
individuals (35). Estimated VFA by BIA was accurate and acces-
sible device is also admitted in obese patients (36, 37). On the 
contrary, some reports have indicated that the validity, reliability, 
and accuracy of BIA were not satisfied (38, 39). Although we did 
TaBle 4 | comparison between parameters stratified by VFa.
VFa < 100 cm2 VFa ≥ 100 cm2 p-Value
N 181 34
Age (years) 66.9 ± 9.8 66.8 ± 9.1 0.985
Sex (n, %male) 68 (37.6) 20 (58.8) 0.017
Weight (kg) 56.1 ± 7.6 73.2 ± 12.4 <0.0001
BMI (kg/m2) 23.3 ± 2.5 27.9 ± 3.5 <0.0001
Waist (cm) 83.8 ± 7.8 95.6 ± 9.3 <0.0001
Systolic BP (mmHg) 136.7 ± 18.7 140.1 ± 19.9 0.338
Diastolic BP (mmHg) 85.2 ± 9.0 87.1 ± 9.9 0.264
Total cholesterol (mg/dl) 203.2 ± 36.0 202.2 ± 51.9 0.888
HDL-cholesterol (mg/dl) 62.6 ± 14.9 54.1 ± 16.2 0.003
LDL-cholesterol (mg/dl) 119.1 ± 28.5 120.7 ± 44.9 0.789
Triglycerides (mg/dl)a 87.0 ± 44.3 128.1 ± 76.1 <0.0001
FPG (mg/dl) 97.5 ± 17.2 116.9 ± 28.9 <0.0001
HbA1c (NGSP) (%) 5.5 ± 0.6 6.0 ± 0.9 0.001
eGFR (ml/min/1.73 m2) 74.2 ± 17.1 73.0 ± 18.5 0.714
Uric acid (mg/dl) 5.1 ± 1.3 5.9 ± 1.2 0.001
hs-CRP (mg/dl)a 0.039 ± 0.131 0.069 ± 0.202 0.023
C-IMT (mm) 0.75 ± 0.14 0.81 ± 0.15 0.027
Data are means ± SDs, geometric mean, range, or percent.
VFA, visceral fat area; BMI, body mass index; BP, blood pressure; HDL, high-density 
lipoprotein; LDL, low-density lipoprotein; FPG, fasting plasma glucose; eGFR, 
estimated glomerular filtration rate; hs-CRP, high sensitivity C-reactive protein; C-IMT, 
carotid intima-media thickness.
aLog-transformed values were used for the analysis.
FigUre 3 | relationship between VFa, waist, and body mass index.
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not examine the validity and accuracy of BIA, Japanese investiga-
tors (40, 41) reported the strong correlations between VFA by 
abdominal CT and VFA by BIA (r = 0.88, p < 0.001), between 
VFA by X-ray CT and VFA by BIA (r =  0.89, p <  0.001). BIA 
also has favorable effects on evaluation of skeletal muscle mass 
(42) and on assessing fat-free mass (43). We consider that VFA 
measurement by this technique can be enough as a screening to 
recognize the accumulation of visceral fat, which leads to MetS 
and increases risks of cerebro-cardiovascular diseases.
VFA levels are significantly associated with metabolic fac-
tors such as waist circumference FPG, and triglycerides. These 
significant associations are remained after adjustment for age and 
sex. The significance of hs-CRP with VFA deserves consideration. 
Report from Turkey (44) is consistent with ours. One mechanism 
for the elevation of hs-CRP in obese individuals might be associ-
ated with a high production of cytokines such as IL-6 and TNF-α 
by the excess adipose tissue, which would induce higher hs-CRP 
production by the liver (45).
The present study has several limitations. First, this study 
was cross-sectional with comparatively a small number of 
subjects. Prospective studies with a large number are needed to 
investigate the evaluation of role of BIA. Second, our popula-
tion was relatively healthy, and most of them had BMI within 
normal limits. Thus, it is necessary to investigate the role of BIA 
in heterogeneous populations. Third, we do not have the data on 
the potential bias caused by metabolic factors such as medication 
and possibility of having edematous diseases. Fourth, although 
this study was performed in the typical fishing area in Japan, 
the background of these subjects may be a little different from 
those of other Japanese people. Fifth, we did not distinguish a 
clinical importance of VSA from SFA and also did not append 
the relationship between the SFA and other variables because 
we did not have data on SFA levels. Finally, we were not able to 
compare DUALSCAN and CT in the enrolled subjects, because 
we have no CT scan data.
In conclusion, our results may suggest that a new simple meas-
urement system of visceral fat accumulation by BIA is useful to 
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